AB Science to present results from its Phase 2B/3 AB07002 study in progressive forms of multiple sclerosis at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting

NEXT STORY
Orthopedic Implants Market to Register a CAGR of 4.1% till 2026 and Reach USD 64.0 Billion by 2026; Increasing Incidence of Osteoporosis to Fuel the Market: Fortune Business Insights
PREV STORY
Novartis post hoc analysis shows high-dose Enerzair® Breezhaler® reduces asthma exacerbations versus medium-dose, complementing key pivotal IRIDIUM study findings
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)

author_avatar
NASDAQ Market News

Global PoC Molecular Diagnostic Market is estimated to be US$ 6.7 Billion by 2029 with a CAGR of 14.8% during the Forecast Period – PMI

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces U.S. Food and Drug Administration (FDA) Accepts Biologics License Application (BLA) for TransCon™ hGH for Pediatric Growth Hormone Deficiency (GHD)

author_avatar
NASDAQ Market News